Literature DB >> 1764030

Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital.

D Argaud1, S Halimi, F Catelloni, X M Leverve.   

Abstract

Gluconeogenesis was studied in hepatocytes isolated from phenobarbital-pretreated rats fasted for 24 h. In closed vial incubations, glucose production from lactate (20 mmol/l) and pyruvate (2 mmol/l), alanine (20 mmol/l) or glutamine (20 mmol/l) was suppressed by about 30-45%, although glycerol metabolism was not affected. In hepatocytes perifused with lactate and pyruvate (ratio 10:1), glucose production was inhibited by 50%, even at low gluconeogenic flux. From the determination of gluconeogenic intermediates at several steady states of gluconeogenic flux, we have found a single relationship between phosphoenolpyruvate and the rate of glucose production (Jglucose), and two different curves between cytosolic oxaloacetate and Jglucose in controls and in phenobarbital-pretreated hepatocytes. By using 3-mercaptopicolinate to determine the flux control coefficient of phosphoenolpyruvate carboxykinase we found that phenobarbital pretreatment led to an increase in this coefficient from 0.3 (controls) to 0.8 (phenobarbital group). These observations were confirmed by the finding that the activity of phosphoenolpyruvate carboxykinase was decreased by 50% after phenobarbital treatment. Hence we conclude that the inhibitory effect of phenobarbital on gluconeogenesis is due, at least partly, to a decrease in the flux through phosphoenolpyruvate carboxykinase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764030      PMCID: PMC1130505          DOI: 10.1042/bj2800663

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Regulatory role of reducing-equivalent transfer from substrate to oxygen in the hepatic metabolism of glycerol and sorbitol.

Authors:  M N Berry; E Kun; H V Werner
Journal:  Eur J Biochem       Date:  1973-03-15

2.  Control of the removal of reducing equivalents from the cytosol in perfused rat liver.

Authors:  J R Williamson; A Jakob; C Refino
Journal:  J Biol Chem       Date:  1971-12-25       Impact factor: 5.157

Review 3.  Regulation of pyruvate metabolism in mammalian tissues.

Authors:  R M Denton; A P Halestrap
Journal:  Essays Biochem       Date:  1979       Impact factor: 8.000

4.  Control of gluconeogenesis in rat liver cells. I. Kinetics of the individual enzymes and the effect of glucagon.

Authors:  A K Groen; R C Vervoorn; R Van der Meer; J M Tager
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

5.  Intracellular compartmentation and control of alanine metabolism in rat liver parenchymal cells.

Authors:  A K Groen; H J Sips; R C Vervoorn; J M Tager
Journal:  Eur J Biochem       Date:  1982-02

6.  The circadian change of gluconeogenesis in the liver in vivo in fed rats.

Authors:  K Kida; T Nishio; T Yokozawa; K Nagai; H Matsuda; H Nakagawa
Journal:  J Biochem       Date:  1980-10       Impact factor: 3.387

7.  Phenobarbital treatment enhances insulin mediated glucose metabolism in man.

Authors:  J T Lahtela; P Särkkä; E A Sotaniemi
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1984-05

8.  Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.

Authors:  E A Sotaniemi; J H Stengård; H U Saarni; A J Arranto; K Keinänen; T Kerola; S Sutinen
Journal:  Acta Med Scand       Date:  1984

9.  3-mercaptopicolinic acid, an inhibitor of gluconeogenesis.

Authors:  N W DiTullio; C E Berkoff; B Blank; V Kostos; E J Stack; H L Saunders
Journal:  Biochem J       Date:  1974-03       Impact factor: 3.857

10.  The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes.

Authors:  J D Best; R G Judzewitsch; M A Pfeifer; J C Beard; J B Halter; D Porte
Journal:  Diabetes       Date:  1982-04       Impact factor: 9.461

View more
  11 in total

1.  Nuclear receptors CAR and PXR in the regulation of hepatic metabolism.

Authors:  E S Tien; M Negishi
Journal:  Xenobiotica       Date:  2006 Oct-Nov       Impact factor: 1.908

2.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 3.  Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism.

Authors:  Jie Gao; Wen Xie
Journal:  Drug Metab Dispos       Date:  2010-08-24       Impact factor: 3.922

4.  Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver.

Authors:  Shawn C Burgess; TianTeng He; Zheng Yan; Jill Lindner; A Dean Sherry; Craig R Malloy; Jeffrey D Browning; Mark A Magnuson
Journal:  Cell Metab       Date:  2007-04       Impact factor: 27.287

Review 5.  Targeting xenobiotic receptors PXR and CAR in human diseases.

Authors:  Monimoy Banerjee; Delira Robbins; Taosheng Chen
Journal:  Drug Discov Today       Date:  2014-11-20       Impact factor: 7.851

Review 6.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Authors:  Jie Gao; Wen Xie
Journal:  Trends Pharmacol Sci       Date:  2012-08-10       Impact factor: 14.819

7.  Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes.

Authors:  Susumu Kodama; Chika Koike; Masahiko Negishi; Yukio Yamamoto
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease.

Authors:  Bingning Dong; Pradip K Saha; Wendong Huang; Wenling Chen; Lutfi A Abu-Elheiga; Salih J Wakil; Robert D Stevens; Olga Ilkayeva; Christopher B Newgard; Lawrence Chan; David D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-22       Impact factor: 11.205

9.  Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene.

Authors:  Susumu Kodama; Rick Moore; Yukio Yamamoto; Masahiko Negishi
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

10.  Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.

Authors:  Dale S Edgerton; Christopher J Ramnanan; Carrie A Grueter; Kathryn M S Johnson; Margaret Lautz; Doss W Neal; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.